Skip to Main Content

Paper Details

Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional study.
Pharmacoepidemiol Drug Saf
9
2016
Author NameAffiliation
Nicholas S DowningCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Joseph S RossCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital
Joseph S RossSection of General Internal Medicine and the Robert Wood Johnson Clinical Scholars Program, Yale University School of Medicine
Joseph S RossYale University School of Public Health
  • 1 - 4

Datasets